Author

Jesse C. Crow

Nationwide Children's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ariunaa BayanjargaliD· 1 shared Aundrietta D. DuncaniD· 1 shared Cenny TaslimiD· 1 shared Emily R. TheiseniD· 1 shared Galen C. RaskiD· 1 shared Julia Selich‐AndersoniD· 1 shared Matthew V. CannoniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ariunaa BayanjargalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins

Galen C. Rask, Cenny Taslim, Ariunaa Bayanjargal, Matthew V. Cannon, Julia Selich‐Anderson, Jesse C. Crow, Aundrietta D. Duncan, Emily R. Theisen

This study shows seclidemstat inhibits the transcriptional activity of multiple FET fusion oncoproteins in vitro, suggesting it as a promising treatment for FET-rearranged sarcomas.

bioRxiv · May 19, 2024 · PreprintCancer Biology